Health Medical

Consumption of highly processed food linked to psoriasis flare-up

Bharti Jayshankar December 4, 2024: The link between highly ultra-processed food (UPF) and various health issues such as obesity, diabetes, cardiovascular risks and.

Read More
Health Pharma

Levothyroxine for hypothyroidism linked to bone loss in older adults

Bharti Jayshankar December 3, 2024: A study conducted by researchers at Johns Hopkins University revealed concerning links between levothyroxine—a commonly prescribed medication for.

Read More
Health Medical

Belly fat during middle age linked to Alzheimer’s disease risk

Bharti Jayshankar December 3, 2024: If you are overweight and have accumulated body fat around your belly in your middle years then you.

Read More
Health

HPV vaccines effective in reducing cervical cancer deaths: A decade of progress

Swati Deshmukh December 2, 2024: The human papillomavirus (HPV) vaccine is significantly reducing cervical cancer deaths in the United States, finds a study..

Read More
Health Medical

Brain shrinkage from Alzheimer’s therapy is desirable, not harmful: Study

Bharti Jayshankar December 2, 2024: A recent study by University College London (UCL) has revealed that the decrease in brain volume observed in.

Read More
Health Pharma

New study finds some healthy breast cells may harbor cancer cells

Bharti Jayshankar November 30, 2024: A study done by the  University of Texas MD Anderson Cancer Center revealed that some breast cells in healthy.

Read More
Drugs Health Medical

Some HRT pills increase risk of heart disease, blood clots

Bharti Jayshankar November 29, 2024: Certain hormone replacement therapy (HRT) pills significantly elevate the risk of heart disease and serious blood clots in.

Read More
Drugs Health

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

Read More
Drugs Health Pharma

Roche to acquire US-based Poseida Therapeutics for $1.5 billion

Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.

Read More
Drugs Health Pharma

Cassava’s disputed Alzheimer’s drug flops in end-stage trials

Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.

Read More